» Articles » PMID: 28299022

Role of Histopathologist in Liver Transplantation

Overview
Date 2017 Mar 17
PMID 28299022
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

A successful liver transplantation team consists of several specialists to work closely together. The histopathologist (anatomical pathologist) is one of the key players in this multidisciplinary team. This role starts with the pre-transplantation evaluation of the recipient's liver by diagnosis or confirming the underlying liver disease and continues with the evaluation of the explanted recipient's liver for any further information about the underlying liver disease including malignancies such as hepatocellular carcinoma, cholangiocarcinoma, or any other incidental findings. The evaluation of the new donor liver begins with determining the suitability of the donor liver for transplantation during or before the operation and continues throughout the entire post-transplantation period by evaluating not only the allograft diseases but also evaluating other tissues for infections, malignancies, . It is worthy to note that in many of the above-mentioned situations, histopathology is the gold-standard diagnostic test. In this review, we present on various tasks of a histopathologist according to the current literature and our own experience in the largest liver transplantation center in Iran.

Citing Articles

Xenoimplant of Collagen Matrix Scaffold in Liver Tissue as a Niche for Liver Cells.

Martinez-Castillo M, Leon-Mancilla B, Ramirez-Rico G, Alfaro A, Perez-Torres A, Diaz-Infante D Front Med (Lausanne). 2022; 9:808191.

PMID: 35463025 PMC: 9022037. DOI: 10.3389/fmed.2022.808191.


Whole Slide Imaging and Its Applications to Histopathological Studies of Liver Disorders.

Melo R, Raas M, Palazzi C, Neves V, Malta K, Silva T Front Med (Lausanne). 2020; 6:310.

PMID: 31970160 PMC: 6960181. DOI: 10.3389/fmed.2019.00310.


Hypertension, but not body mass index, is predictive of increased pancreatic lipid content and islet dysfunction.

Tremmel D, Feeney A, Mitchell S, Chlebeck P, Raglin S, Fernandez L Am J Transplant. 2019; 20(4):1105-1115.

PMID: 31715064 PMC: 7103563. DOI: 10.1111/ajt.15698.


Molecular diagnosis of glycogen storage disease type I: a review.

Beyzaei Z, Geramizadeh B EXCLI J. 2019; 18:30-46.

PMID: 30956637 PMC: 6449677.

References
1.
Valente M, Calabrese F, Angelini A, Castiglione A, Rigotti P, Ragani M . Role of the pathologist in organ transplantation: the North Italy Transplant program experience. Transplant Proc. 2006; 38(4):983-5. DOI: 10.1016/j.transproceed.2006.03.041. View

2.
Senkerikova R, Frankova S, Sperl J, Oliverius M, Kieslichova E, Filipova H . Incidental hepatocellular carcinoma: risk factors and long-term outcome after liver transplantation. Transplant Proc. 2014; 46(5):1426-9. DOI: 10.1016/j.transproceed.2014.03.010. View

3.
Bahador A, Dehghani S, Geramizadeh B, Nikeghbalian S, Bahador M, Malekhosseini S . Liver Transplant for Children With Hepatocellular Carcinoma and Hereditary Tyrosinemia Type 1. Exp Clin Transplant. 2014; 13(4):329-32. DOI: 10.6002/ect.2013.0158. View

4.
Geramizadeh B, Nikeghbalian S, Dehghani S, Bahador A, Salahi H, Malekhosseini S . Primary Involvement of Allografted liver in Post-Transplant Lymphoproliferative Disorders, Report of Two Pediatric Cases and Review of the Literature. Iran Red Crescent Med J. 2013; 14(11):719-21. PMC: 3560542. DOI: 10.5812/ircmj.1134. View

5.
Flechtenmacher C, Schirmacher P, Schemmer P . Donor liver histology--a valuable tool in graft selection. Langenbecks Arch Surg. 2015; 400(5):551-7. DOI: 10.1007/s00423-015-1298-7. View